Medical device manufacturers are continually increasing the processing capabilities of patient monitors, specifically of patient monitors that process signals based on attenuation of light by patient tissue. In general, such patient monitoring systems include one or more optical sensors that irradiate tissue of a patient and one or more photodetectors that detect the radiation after attenuation thereof by the tissue. The sensor communicates the detected signal to a patient monitor, where the monitor often removes noise and preprocesses the signal. Advanced signal processors then perform time domain and/or frequency domain processing to determine measurements of blood constituents and other physiological parameters of the patient.
Manufacturers have advanced basic pulse oximeters that determine measurements for blood oxygen saturation (“SpO2”), pulse rate (“PR”) and pethysmographic information, to read-through-motion oximeters, to co-oximeters that determine measurements of many constituents of circulating blood. For example, Masimo Corporation of Irvine Calif (“Masimo”) manufactures pulse oximetry systems including Masimo SET® low noise optical sensors and read through motion pulse oximetry monitors for measuring SpO2, PR, perfusion index (“Pl”) and others. Masimo sensors include any of LNOP®, LNCS®, SofTouch™ and Blue™ adhesive or reusable sensors. Masimo oximetry monitors include any of Rad-8®, Rad-5®, Rad®-5v or SatShare® monitors.
Many innovations improving the measurement of blood constituents are described in at least U.S. Pat. Nos. 6,770,028; 6,658,276; 6,157,850; 6,002,952; 5,769,785 and 5,758,644, which are assigned to Masimo and are incorporated by reference herein. Corresponding low noise optical sensors are disclosed in at least U.S. Pat. Nos. 6,985,764; 6,088,607; 5,782,757 and 5,638,818, assigned to Masimo and hereby incorporated in their entirety by reference herein.
Masimo also manufactures more advanced co-oximeters including Masimo Rainbow® SET, which provides measurements in addition to SpO2, such as total hemoglobin (SpHb™), oxygen content (SpCO™), methemoglobin (SpMet®), carboxyhemoglobin (SpCO®) and PVI®. Advanced blood parameter sensors include Masimo Rainbow® adhesive, ReSposable™ and reusable sensors. Masimo's advanced blood parameter monitors include Masimo Radical-7™, Rad87™, and Rad57™ monitors as well as Pronto and Pronto-7 spot check monitors.
Innovations relating to these more advanced blood parameter measurement systems are described in at least U.S. Pat. Nos. 7,647,083; 7,729,733; U.S. Pat. Pub. Nos. 2006/0211925; and 2006/0238358, assigned to Cercacor Laboratories of Irvine, Calif. (“Cercacor”) and hereby incorporated in their entirety by reference herein.
Such advanced pulse oximeters, low noise sensors and advanced blood parameter systems have gained rapid acceptance in a wide variety of medical applications, including surgical wards, intensive care and neonatal units, general wards, home care, physical training, and virtually all types of monitoring scenarios.
Advanced pulse oximetry is described in at least U.S. Pat. Nos. 6,770,028; 6,658,276; 6,157,850; 6,002,952; 5,769,785 and 5,758,644, which are assigned to Masimo Corporation (“Masimo”) of Irvine, California and are incorporated in their entirety by reference herein. Corresponding low noise optical sensors are disclosed in at least U.S. Pat. Nos. 6,985,764; 6,813,511; 6,792,300; 6,256,523; 6,088,607; 5,782,757 and 5,638,818, which are also assigned to Masimo and are also incorporated in their entirety by reference herein. Advanced pulse oximetry systems including Masimo SET® low noise optical sensors and read through motion pulse oximetry monitors for measuring SpO2, pulse rate (PR) and perfusion index (Pl) are available from Masimo. Optical sensors include any of Masimo LNOP®, LNCS®, SofTouch™ and Blue™ adhesive or reusable sensors. Pulse oximetry monitors include any of Masimo Rad-8®, Rad-5®, Rad®-5v or SatShare® monitors.
Advanced blood parameter measurement systems are described in at least U.S. Pat. No. 7,647,083, filed Mar. 1, 2006, titled Multiple Wavelength Sensor Equalization; U.S. Pat. No. 7,729,733, filed Mar. 1, 2006, titled Configurable Physiological Measurement System; U.S. Pat. Pub. No. 2006/0211925, filed Mar. 1, 2006, titled Physiological Parameter Confidence Measure and U.S. Pat. Pub. No. 2006/0238358, filed Mar. 1, 2006, titled Noninvasive Multi-Parameter Patient Monitor, all assigned to Cercacor Laboratories, Inc., Irvine, CA (Cercacor) and all incorporated in their entirety by reference herein. An advanced parameter measurement system that includes acoustic monitoring is described in U.S. Pat. Pub. No. 2010/027 4099, filed Dec. 21, 2009, titled Acoustic Sensor Assembly, assigned to Masimo and incorporated in its entirety by reference herein.
Advanced blood parameter measurement systems include Masimo Rainbow® SET, which provides measurements in addition to SpO2, such as total hemoglobin (SpHb™), oxygen content (SpOC™), methemoglobin (SpMet®), carboxyhemoglobin (SpCO®) and PVI®. Advanced blood parameter sensors include Masimo Rainbow® adhesive, ReSposable™ and reusable sensors. Advanced blood parameter monitors include Masimo Radical-7™, Rad87™ and Rad57™ monitors, all available from Masimo. Advanced parameter measurement systems may also include acoustic monitoring such as acoustic respiration rate (RRa™) using a Rainbow Acoustic Sensor™ and Rad87™ monitor, available from Masimo. Such advanced pulse oximeters, low noise sensors and advanced parameter systems have gained rapid acceptance in a wide variety of medical applications, including surgical wards, intensive care and neonatal units, general wards, home care, physical training, and virtually all types of monitoring scenarios.
An avatar-incentive healthcare therapy system has a physiological monitor for generating a physiological parameter indicative of physical health. An academic test for generating a test score is indicative of mental acuity. The avatar has outward characteristics and game play capabilities proportional to the physiological health and the mental acuity so as to incentivize improved physical health and academic performance.
As shown in
Also shown in
In an embodiment, an avatar summary screen 122 is presented in the game play mode 102 illustrating the player's selected avatar 180 and indicators 190 of the avatar's accumulated physical strength and mental prowess. With respect to physical strength, the physiological monitor 100 is in wireless or wired communications with, for example, exercise equipment so as to incentivize patients recovering from, say, accidents or surgery to track physical exercise and healing progress. With respect to mental prowess, the physiological monitor 100 is in communications with mental skill test results, where the mental skills are either presented by the physiological monitor 100 itself in a mental challenge mode or input to the monitor 100 from external indicators of mental achievements, such as student report cards and standardized test results, to name a few.
In other embodiments, the physiological monitor 100 measures, records and tracks a person's physiological measurements such as resting heart rate, cholesterol, blood pressure among other physiological parameters. The person's avatar becomes physically stronger according to a health index based upon these parameters. Likewise, if a person passes certain quizzes or has a report card with straight A's, that person's avatar gets stronger and smarter for games simulating physical competition, such as racing, sports and combat. Advantageously, the physiological monitor 100 helps patients recovering from a stroke, provides a sports training tool for athletes and functions as a student teaching device, as a few examples.
The present application claims priority benefit under 35 U.S.C. § 119(e) to U.S. patent application Ser. No. 17/372,229 filed Jul. 9, 2021, titled Avatar-Incentive Healthcare Therapy; U.S. Pat. No. 11,058,942, issued Jul. 13, 2021, titled Avatar-Incentive Healthcare Therapy; U.S. Pat. No. 10,881,951, issued Jan. 5, 2021, titled Avatar-Incentive Healthcare Therapy; U.S. Pat. No. 10,279,247, issued May 7, 2019, titled Avatar-Incentive Healthcare Therapy; and U.S. Provisional Patent Application Ser. No. 61/916,136 filed Dec. 13, 2013, titled Avatar Incentive Video Game, hereby incorporated in its entirety by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
4960128 | Gordon et al. | Oct 1990 | A |
4964408 | Hink et al. | Oct 1990 | A |
5319355 | Russek | Jun 1994 | A |
5337744 | Branigan | Aug 1994 | A |
5341805 | Stavridi et al. | Aug 1994 | A |
D353195 | Savage et al. | Dec 1994 | S |
D353196 | Savage et al. | Dec 1994 | S |
5377676 | Vari et al. | Jan 1995 | A |
D359546 | Savage et al. | Jun 1995 | S |
5431170 | Mathews | Jul 1995 | A |
5436499 | Namavar et al. | Jul 1995 | A |
D361840 | Savage et al. | Aug 1995 | S |
D362063 | Savage et al. | Sep 1995 | S |
D363120 | Savage et al. | Oct 1995 | S |
5456252 | Vari et al. | Oct 1995 | A |
5479934 | Imran | Jan 1996 | A |
5482036 | Diab et al. | Jan 1996 | A |
5494043 | O'Sullivan et al. | Feb 1996 | A |
5533511 | Kaspari et al. | Jul 1996 | A |
5561275 | Savage et al. | Oct 1996 | A |
5590649 | Caro et al. | Jan 1997 | A |
5602924 | Durand et al. | Feb 1997 | A |
5638816 | Kiani-Azarbayjany et al. | Jun 1997 | A |
5638818 | Diab et al. | Jun 1997 | A |
5645440 | Tobler et al. | Jul 1997 | A |
5671914 | Kalkhoran et al. | Sep 1997 | A |
5726440 | Kalkhoran et al. | Mar 1998 | A |
D393830 | Tobler et al. | Apr 1998 | S |
5743262 | Lepper, Jr. et al. | Apr 1998 | A |
5747806 | Khalil et al. | May 1998 | A |
5750994 | Schlager | May 1998 | A |
5758644 | Diab et al. | Jun 1998 | A |
5760910 | Lepper, Jr. et al. | Jun 1998 | A |
5890929 | Mills et al. | Apr 1999 | A |
5919134 | Diab | Jul 1999 | A |
5987343 | Kinast | Nov 1999 | A |
5997343 | Mills et al. | Dec 1999 | A |
6002952 | Diab et al. | Dec 1999 | A |
6010937 | Karam et al. | Jan 2000 | A |
6027452 | Flaherty et al. | Feb 2000 | A |
6040578 | Malin et al. | Mar 2000 | A |
6066204 | Haven | May 2000 | A |
6115673 | Malin et al. | Sep 2000 | A |
6124597 | Shehada et al. | Sep 2000 | A |
6128521 | Marro et al. | Oct 2000 | A |
6129675 | Jay | Oct 2000 | A |
6144868 | Parker | Nov 2000 | A |
6152754 | Gerhardt et al. | Nov 2000 | A |
6184521 | Coffin, IV et al. | Feb 2001 | B1 |
6232609 | Snyder et al. | May 2001 | B1 |
6241683 | Macklem et al. | Jun 2001 | B1 |
6255708 | Sudharsanan et al. | Jul 2001 | B1 |
6280381 | Malin et al. | Aug 2001 | B1 |
6285896 | Tobler et al. | Sep 2001 | B1 |
6308089 | von der Ruhr et al. | Oct 2001 | B1 |
6317627 | Ennen et al. | Nov 2001 | B1 |
6321100 | Parker | Nov 2001 | B1 |
6334065 | Al-Ali et al. | Dec 2001 | B1 |
6360114 | Diab et al. | Mar 2002 | B1 |
6368283 | Xu et al. | Apr 2002 | B1 |
6411373 | Garside et al. | Jun 2002 | B1 |
6415167 | Blank et al. | Jul 2002 | B1 |
6430437 | Marro | Aug 2002 | B1 |
6430525 | Weber et al. | Aug 2002 | B1 |
6463311 | Diab | Oct 2002 | B1 |
6470199 | Kopotic et al. | Oct 2002 | B1 |
6487429 | Hockersmith et al. | Nov 2002 | B2 |
6505059 | Kollias et al. | Jan 2003 | B1 |
6525386 | Mills et al. | Feb 2003 | B1 |
6526300 | Kiani et al. | Feb 2003 | B1 |
6534012 | Hazen et al. | Mar 2003 | B1 |
6542764 | Al-Ali et al. | Apr 2003 | B1 |
6580086 | Schulz et al. | Jun 2003 | B1 |
6584336 | Ali et al. | Jun 2003 | B1 |
6587196 | Stippick et al. | Jul 2003 | B1 |
6587199 | Luu | Jul 2003 | B1 |
6595316 | Cybulski et al. | Jul 2003 | B2 |
6597932 | Tian et al. | Jul 2003 | B2 |
6606511 | Ali et al. | Aug 2003 | B1 |
6635559 | Greenwald et al. | Oct 2003 | B2 |
6639668 | Trepagnier | Oct 2003 | B1 |
6640116 | Diab | Oct 2003 | B2 |
6640117 | Makarewicz et al. | Oct 2003 | B2 |
6658276 | Kiani et al. | Dec 2003 | B2 |
6661161 | Lanzo et al. | Dec 2003 | B1 |
6697656 | Al-Ali | Feb 2004 | B1 |
6697658 | Al-Ali | Feb 2004 | B2 |
RE38476 | Diab et al. | Mar 2004 | E |
RE38492 | Diab et al. | Apr 2004 | E |
6738652 | Mattu et al. | May 2004 | B2 |
6760607 | Al-Ali | Jul 2004 | B2 |
6788965 | Ruchti et al. | Sep 2004 | B2 |
6816241 | Grubisic | Nov 2004 | B2 |
6822564 | Al-Ali | Nov 2004 | B2 |
6850787 | Weber et al. | Feb 2005 | B2 |
6850788 | Al-Ali | Feb 2005 | B2 |
6876931 | Lorenz et al. | Apr 2005 | B2 |
6920345 | Al-Ali et al. | Jul 2005 | B2 |
6934570 | Kiani et al. | Aug 2005 | B2 |
6943348 | Coffin IV | Sep 2005 | B1 |
6956649 | Acosta et al. | Oct 2005 | B2 |
6961598 | Diab | Nov 2005 | B2 |
6970792 | Diab | Nov 2005 | B1 |
6985764 | Mason et al. | Jan 2006 | B2 |
6990364 | Ruchti et al. | Jan 2006 | B2 |
6998247 | Monfre et al. | Feb 2006 | B2 |
7003338 | Weber et al. | Feb 2006 | B2 |
7015451 | Dalke et al. | Mar 2006 | B2 |
7027849 | Al-Ali | Apr 2006 | B2 |
D526719 | Richie, Jr. et al. | Aug 2006 | S |
7096052 | Mason et al. | Aug 2006 | B2 |
7096054 | Abdul-Hafiz et al. | Aug 2006 | B2 |
D529616 | Deros et al. | Oct 2006 | S |
7133710 | Acosta et al. | Nov 2006 | B2 |
7142901 | Kiani et al. | Nov 2006 | B2 |
7225006 | Al-Ali et al. | May 2007 | B2 |
RE39672 | Shehada et al. | Jun 2007 | E |
7254429 | Schurman et al. | Aug 2007 | B2 |
7254431 | Al-Ali et al. | Aug 2007 | B2 |
7254434 | Schulz et al. | Aug 2007 | B2 |
7274955 | Kiani et al. | Sep 2007 | B2 |
D554263 | Al-Ali et al. | Oct 2007 | S |
7280858 | Al-Ali et al. | Oct 2007 | B2 |
7289835 | Mansfield et al. | Oct 2007 | B2 |
7292883 | De Felice et al. | Nov 2007 | B2 |
7341559 | Schulz et al. | Mar 2008 | B2 |
7343186 | Lamego et al. | Mar 2008 | B2 |
D566282 | Al-Ali et al. | Apr 2008 | S |
7356365 | Schurman | Apr 2008 | B2 |
7371981 | Abdul-Hafiz | May 2008 | B2 |
7373193 | Al-Ali et al. | May 2008 | B2 |
7377794 | Al-Ali et al. | May 2008 | B2 |
7395158 | Monfre et al. | Jul 2008 | B2 |
7415297 | Al-Ali et al. | Aug 2008 | B2 |
7438683 | Al-Ali et al. | Oct 2008 | B2 |
7483729 | Al-Ali et al. | Jan 2009 | B2 |
D587657 | Al-Ali et al. | Mar 2009 | S |
7500950 | Al-Ali et al. | Mar 2009 | B2 |
7509494 | Al-Ali | Mar 2009 | B2 |
7510849 | Schurman et al. | Mar 2009 | B2 |
7514725 | Wojtczuk et al. | Apr 2009 | B2 |
7519406 | Blank et al. | Apr 2009 | B2 |
D592507 | Wachman et al. | May 2009 | S |
7530942 | Diab | May 2009 | B1 |
7593230 | Abul-Haj et al. | Sep 2009 | B2 |
7596398 | Al-Ali et al. | Sep 2009 | B2 |
7606608 | Blank et al. | Oct 2009 | B2 |
7620674 | Ruchti et al. | Nov 2009 | B2 |
D606659 | Kiani et al. | Dec 2009 | S |
7629039 | Eckerbom et al. | Dec 2009 | B2 |
7640140 | Ruchti et al. | Dec 2009 | B2 |
7647083 | Al-Ali et al. | Jan 2010 | B2 |
D609193 | Al-Ali et al. | Feb 2010 | S |
D614305 | Al-Ali et al. | Apr 2010 | S |
7697966 | Monfre et al. | Apr 2010 | B2 |
7698105 | Ruchti et al. | Apr 2010 | B2 |
RE41317 | Parker | May 2010 | E |
RE41333 | Blank et al. | May 2010 | E |
7729733 | Al-Ali et al. | Jun 2010 | B2 |
7761127 | Al-Ali et al. | Jul 2010 | B2 |
7764982 | Dalke et al. | Jul 2010 | B2 |
D621516 | Kiani et al. | Aug 2010 | S |
7791155 | Diab | Sep 2010 | B2 |
RE41912 | Parker | Nov 2010 | E |
7880626 | Al-Ali et al. | Feb 2011 | B2 |
7909772 | Popov et al. | Mar 2011 | B2 |
7919713 | Al-Ali et al. | Apr 2011 | B2 |
7937128 | Al-Ali | May 2011 | B2 |
7937129 | Mason et al. | May 2011 | B2 |
7941199 | Kiani | May 2011 | B2 |
7957780 | Lamego et al. | Jun 2011 | B2 |
7962188 | Kiani et al. | Jun 2011 | B2 |
7976472 | Kiani | Jul 2011 | B2 |
7990382 | Kiani | Aug 2011 | B2 |
8008088 | Bellott et al. | Aug 2011 | B2 |
RE42753 | Kiani-Azarbayjany et al. | Sep 2011 | E |
8028701 | Al-Ali et al. | Oct 2011 | B2 |
8048040 | Kiani | Nov 2011 | B2 |
8050728 | Al-Ali et al. | Nov 2011 | B2 |
RE43169 | Parker | Feb 2012 | E |
8118620 | Al-Ali et al. | Feb 2012 | B2 |
8130105 | Al-Ali et al. | Mar 2012 | B2 |
8182443 | Kiani | May 2012 | B1 |
8190223 | Al-Ali et al. | May 2012 | B2 |
8203438 | Kiani et al. | Jun 2012 | B2 |
8203704 | Merritt et al. | Jun 2012 | B2 |
8219172 | Schurman et al. | Jul 2012 | B2 |
8224411 | Al-Ali et al. | Jul 2012 | B2 |
8229532 | Davis | Jul 2012 | B2 |
8233955 | Al-Ali et al. | Jul 2012 | B2 |
8255026 | Al-Ali | Aug 2012 | B1 |
8265723 | McHale et al. | Sep 2012 | B1 |
8274360 | Sampath et al. | Sep 2012 | B2 |
8280473 | Al-Ali | Oct 2012 | B2 |
8315683 | Al-Ali et al. | Nov 2012 | B2 |
RE43860 | Parker | Dec 2012 | E |
8346330 | Lamego | Jan 2013 | B2 |
8353842 | Al-Ali et al. | Jan 2013 | B2 |
8355766 | MacNeish, III et al. | Jan 2013 | B2 |
8374665 | Lamego | Feb 2013 | B2 |
8388353 | Kiani et al. | Mar 2013 | B2 |
8401602 | Kiani | Mar 2013 | B2 |
8414499 | Al-Ali et al. | Apr 2013 | B2 |
8418524 | Al-Ali | Apr 2013 | B2 |
8428967 | Olsen et al. | Apr 2013 | B2 |
8430817 | Al-Ali et al. | Apr 2013 | B1 |
8437825 | Dalvi et al. | May 2013 | B2 |
8455290 | Siskavich | Jun 2013 | B2 |
8457707 | Kiani | Jun 2013 | B2 |
8471713 | Poeze et al. | Jun 2013 | B2 |
8473020 | Kiani et al. | Jun 2013 | B2 |
8509867 | Workman et al. | Aug 2013 | B2 |
8515509 | Bruinsma et al. | Aug 2013 | B2 |
8523781 | Al-Ali | Sep 2013 | B2 |
D692145 | Al-Ali et al. | Oct 2013 | S |
8571617 | Reichgott et al. | Oct 2013 | B2 |
8571618 | Lamego et al. | Oct 2013 | B1 |
8571619 | Al-Ali et al. | Oct 2013 | B2 |
8577431 | Lamego et al. | Nov 2013 | B2 |
8584345 | Al-Ali et al. | Nov 2013 | B2 |
8588880 | Abdul-Hafiz et al. | Nov 2013 | B2 |
8630691 | Lamego et al. | Jan 2014 | B2 |
8641631 | Sierra et al. | Feb 2014 | B2 |
8652060 | Al-Ali | Feb 2014 | B2 |
8666468 | Al-Ali | Mar 2014 | B1 |
8670811 | O'Reilly | Mar 2014 | B2 |
RE44823 | Parker | Apr 2014 | E |
RE44875 | Kiani et al. | Apr 2014 | E |
8688183 | Bruinsma et al. | Apr 2014 | B2 |
8690799 | Telfort et al. | Apr 2014 | B2 |
8702627 | Telfort et al. | Apr 2014 | B2 |
8712494 | MacNeish, III et al. | Apr 2014 | B1 |
8715206 | Telfort et al. | May 2014 | B2 |
8723677 | Kiani | May 2014 | B1 |
8740792 | Kiani et al. | Jun 2014 | B1 |
8755535 | Telfort et al. | Jun 2014 | B2 |
8755872 | Marinow | Jun 2014 | B1 |
8764671 | Kiani | Jul 2014 | B2 |
8768423 | Shakespeare et al. | Jul 2014 | B2 |
8771204 | Telfort et al. | Jul 2014 | B2 |
8781544 | Al-Ali et al. | Jul 2014 | B2 |
8790268 | Al-Ali | Jul 2014 | B2 |
8801613 | Al-Ali et al. | Aug 2014 | B2 |
8821397 | Al-Ali et al. | Sep 2014 | B2 |
8821415 | Al-Ali et al. | Sep 2014 | B2 |
8830449 | Lamego et al. | Sep 2014 | B1 |
8840549 | Al-Ali et al. | Sep 2014 | B2 |
8852094 | Al-Ali et al. | Oct 2014 | B2 |
8852994 | Wojtczuk et al. | Oct 2014 | B2 |
8897847 | Al-Ali | Nov 2014 | B2 |
8911377 | Al-Ali | Dec 2014 | B2 |
8989831 | Al-Ali et al. | Mar 2015 | B2 |
8998809 | Kiani | Apr 2015 | B2 |
9022930 | Sachanandani et al. | May 2015 | B2 |
9066666 | Kiani | Jun 2015 | B2 |
9066680 | Al-Ali et al. | Jun 2015 | B1 |
9095316 | Welch et al. | Aug 2015 | B2 |
9106038 | Telfort et al. | Aug 2015 | B2 |
9107625 | Telfort et al. | Aug 2015 | B2 |
9131881 | Diab et al. | Sep 2015 | B2 |
9138180 | Coverston et al. | Sep 2015 | B1 |
9153112 | Kiani et al. | Oct 2015 | B1 |
9192329 | Al-Ali | Nov 2015 | B2 |
9192351 | Telfort et al. | Nov 2015 | B1 |
9195385 | Al-Ali et al. | Nov 2015 | B2 |
9211095 | Al-Ali | Dec 2015 | B1 |
9218454 | Kiani et al. | Dec 2015 | B2 |
9245668 | Vo et al. | Jan 2016 | B1 |
9267572 | Barker et al. | Feb 2016 | B2 |
9277880 | Poeze et al. | Mar 2016 | B2 |
9307928 | Al-Ali et al. | Apr 2016 | B1 |
9323894 | Kiani | Apr 2016 | B2 |
D755392 | Hwang et al. | May 2016 | S |
9326712 | Kiani | May 2016 | B1 |
9392945 | Al-Ali et al. | Jul 2016 | B2 |
9408542 | Kinast et al. | Aug 2016 | B1 |
9436645 | Al-Ali et al. | Sep 2016 | B2 |
9445759 | Lamego et al. | Sep 2016 | B1 |
9474474 | Lamego et al. | Oct 2016 | B2 |
9480435 | Olsen | Nov 2016 | B2 |
9510779 | Poeze et al. | Dec 2016 | B2 |
9517024 | Kiani et al. | Dec 2016 | B2 |
9532722 | Lamego et al. | Jan 2017 | B2 |
9560996 | Kiani | Feb 2017 | B2 |
9579039 | Jansen et al. | Feb 2017 | B2 |
9622692 | Lamego et al. | Apr 2017 | B2 |
D788312 | Al-Ali et al. | May 2017 | S |
9649054 | Lamego et al. | May 2017 | B2 |
9697928 | Al-Ali et al. | Jul 2017 | B2 |
9717458 | Lamego et al. | Aug 2017 | B2 |
9724016 | Al-Ali et al. | Aug 2017 | B1 |
9724024 | Al-Ali | Aug 2017 | B2 |
9724025 | Kiani et al. | Aug 2017 | B1 |
9749232 | Sampath et al. | Aug 2017 | B2 |
9750442 | Olsen | Sep 2017 | B2 |
9750461 | Telfort | Sep 2017 | B1 |
9775545 | Al-Ali et al. | Oct 2017 | B2 |
9778079 | Al-Ali et al. | Oct 2017 | B1 |
9782077 | Lamego et al. | Oct 2017 | B2 |
9787568 | Lamego et al. | Oct 2017 | B2 |
9808188 | Perea et al. | Nov 2017 | B1 |
9839379 | Al-Ali et al. | Dec 2017 | B2 |
9839381 | Weber et al. | Dec 2017 | B1 |
9847749 | Kiani et al. | Dec 2017 | B2 |
9848800 | Lee et al. | Dec 2017 | B1 |
9861298 | Eckerbom et al. | Jan 2018 | B2 |
9861305 | Weber et al. | Jan 2018 | B1 |
9877650 | Muhsin et al. | Jan 2018 | B2 |
9891079 | Dalvi | Feb 2018 | B2 |
9924897 | Abdul-Hafiz | Mar 2018 | B1 |
9936917 | Poeze et al. | Apr 2018 | B2 |
9955937 | Telfort | May 2018 | B2 |
9965946 | Al-Ali et al. | May 2018 | B2 |
D820865 | Muhsin et al. | Jun 2018 | S |
9986952 | Dalvi et al. | Jun 2018 | B2 |
D822215 | Al-Ali et al. | Jul 2018 | S |
D822216 | Barker et al. | Jul 2018 | S |
10010276 | Al-Ali et al. | Jul 2018 | B2 |
10086138 | Novak, Jr. | Oct 2018 | B1 |
10111591 | Dyell et al. | Oct 2018 | B2 |
D833624 | DeJong et al. | Nov 2018 | S |
10123729 | Dyell et al. | Nov 2018 | B2 |
D835282 | Barker et al. | Dec 2018 | S |
D835283 | Barker et al. | Dec 2018 | S |
D835284 | Barker et al. | Dec 2018 | S |
D835285 | Barker et al. | Dec 2018 | S |
10149616 | Al-Ali et al. | Dec 2018 | B2 |
10154815 | Al-Ali et al. | Dec 2018 | B2 |
10159412 | Lamego et al. | Dec 2018 | B2 |
10188348 | Al-Ali et al. | Jan 2019 | B2 |
RE47218 | Al-Ali | Feb 2019 | E |
RE47244 | Kiani et al. | Feb 2019 | E |
RE47249 | Kiani et al. | Feb 2019 | E |
10205291 | Scruggs et al. | Feb 2019 | B2 |
10226187 | Al-Ali et al. | Mar 2019 | B2 |
10231657 | Al-Ali et al. | Mar 2019 | B2 |
10231670 | Blank et al. | Mar 2019 | B2 |
RE47353 | Kiani et al. | Apr 2019 | E |
10279247 | Kiani | May 2019 | B2 |
10292664 | Al-Ali | May 2019 | B2 |
10299720 | Brown et al. | May 2019 | B2 |
10327337 | Schmidt et al. | Jun 2019 | B2 |
10327713 | Barker et al. | Jun 2019 | B2 |
10332630 | Al-Ali | Jun 2019 | B2 |
10383520 | Wojtczuk et al. | Aug 2019 | B2 |
10383527 | Al-Ali | Aug 2019 | B2 |
10388120 | Muhsin et al. | Aug 2019 | B2 |
D864120 | Forrest et al. | Oct 2019 | S |
10441181 | Telfort et al. | Oct 2019 | B1 |
10441196 | Eckerbom et al. | Oct 2019 | B2 |
10448844 | Al-Ali et al. | Oct 2019 | B2 |
10448871 | Al-Ali et al. | Oct 2019 | B2 |
10456038 | Lamego et al. | Oct 2019 | B2 |
10463340 | Telfort et al. | Nov 2019 | B2 |
10471159 | Lapotko et al. | Nov 2019 | B1 |
10505311 | Al-Ali et al. | Dec 2019 | B2 |
10524738 | Olsen | Jan 2020 | B2 |
10532174 | Ai-Ali | Jan 2020 | B2 |
10537285 | Shreim et al. | Jan 2020 | B2 |
10542903 | Al-Ali et al. | Jan 2020 | B2 |
10555678 | Dalvi et al. | Feb 2020 | B2 |
10568553 | O'Neil et al. | Feb 2020 | B2 |
RE47882 | Al-Ali | Mar 2020 | E |
10608817 | Haider et al. | Mar 2020 | B2 |
D880477 | Forrest et al. | Apr 2020 | S |
10617302 | Al-Ali et al. | Apr 2020 | B2 |
10617335 | Al-Ali et al. | Apr 2020 | B2 |
10637181 | Al-Ali et al. | Apr 2020 | B2 |
D886849 | Muhsin et al. | Jun 2020 | S |
D887548 | Abdul-Hafiz et al. | Jun 2020 | S |
D887549 | Abdul-Hafiz et al. | Jun 2020 | S |
10667764 | Ahmed et al. | Jun 2020 | B2 |
D890708 | Forrest et al. | Jul 2020 | S |
10721785 | Al-Ali | Jul 2020 | B2 |
10736518 | Al-Ali et al. | Aug 2020 | B2 |
10750984 | Pauley et al. | Aug 2020 | B2 |
D897098 | Al-Ali | Sep 2020 | S |
10779098 | Iswanto et al. | Sep 2020 | B2 |
10827961 | Iyengar et al. | Nov 2020 | B1 |
10828007 | Telfort et al. | Nov 2020 | B1 |
10832818 | Muhsin et al. | Nov 2020 | B2 |
10849554 | Shreim et al. | Dec 2020 | B2 |
10856750 | Indorf | Dec 2020 | B2 |
D906970 | Forrest et al. | Jan 2021 | S |
D908213 | Abdul-Hafiz et al. | Jan 2021 | S |
10918281 | Al-Ali et al. | Feb 2021 | B2 |
10932705 | Muhsin et al. | Mar 2021 | B2 |
10932729 | Kiani et al. | Mar 2021 | B2 |
10939878 | Kiani et al. | Mar 2021 | B2 |
10956950 | Al-Ali et al. | Mar 2021 | B2 |
D916135 | Indorf et al. | Apr 2021 | S |
D917046 | Abdul-Hafiz et al. | Apr 2021 | S |
D917550 | Indorf et al. | Apr 2021 | S |
D917564 | Indorf et al. | Apr 2021 | S |
D917704 | Al-Ali et al. | Apr 2021 | S |
10987066 | Chandran et al. | Apr 2021 | B2 |
10991135 | Al-Ali et al. | Apr 2021 | B2 |
D919094 | Al-Ali et al. | May 2021 | S |
D919100 | Al-Ali et al. | May 2021 | S |
11006867 | Al-Ali | May 2021 | B2 |
D921202 | Al-Ali et al. | Jun 2021 | S |
11024064 | Muhsin et al. | Jun 2021 | B2 |
11026604 | Chen et al. | Jun 2021 | B2 |
D925597 | Chandran et al. | Jul 2021 | S |
11058942 | Kiani | Jul 2021 | B2 |
D927699 | Al-Ali et al. | Aug 2021 | S |
11076777 | Lee et al. | Aug 2021 | B2 |
11114188 | Poeze et al. | Sep 2021 | B2 |
D933232 | Al-Ali et al. | Oct 2021 | S |
D933233 | Al-Ali et al. | Oct 2021 | S |
D933234 | Al-Ali et al. | Oct 2021 | S |
11145408 | Sampath et al. | Oct 2021 | B2 |
11147518 | Al-Ali et al. | Oct 2021 | B1 |
11185262 | Al-Ali et al. | Nov 2021 | B2 |
11191484 | Kiani et al. | Dec 2021 | B2 |
D946596 | Ahmed | Mar 2022 | S |
D946597 | Ahmed | Mar 2022 | S |
D946598 | Ahmed | Mar 2022 | S |
D946617 | Ahmed | Mar 2022 | S |
11272839 | Al-Ali et al. | Mar 2022 | B2 |
11289199 | Al-Ali | Mar 2022 | B2 |
RE49034 | Al-Ali | Apr 2022 | E |
11298021 | Muhsin et al. | Apr 2022 | B2 |
D950580 | Ahmed | May 2022 | S |
D950599 | Ahmed | May 2022 | S |
D950738 | Al-Ali et al. | May 2022 | S |
D957648 | Al-Ali | Jul 2022 | S |
11382567 | O'Brien et al. | Jul 2022 | B2 |
11389093 | Triman et al. | Jul 2022 | B2 |
11406286 | Al-Ali et al. | Aug 2022 | B2 |
11417426 | Muhsin et al. | Aug 2022 | B2 |
11439329 | Lamego | Sep 2022 | B2 |
11445948 | Scruggs et al. | Sep 2022 | B2 |
D965789 | Al-Ali et al. | Oct 2022 | S |
D967433 | Al-Ali et al. | Oct 2022 | S |
11464410 | Muhsin | Oct 2022 | B2 |
11504058 | Sharma et al. | Nov 2022 | B1 |
11504066 | Dalvi et al. | Nov 2022 | B1 |
D971933 | Ahmed | Dec 2022 | S |
D973072 | Ahmed | Dec 2022 | S |
D973685 | Ahmed | Dec 2022 | S |
D973686 | Ahmed | Dec 2022 | S |
D974193 | Forrest et al. | Jan 2023 | S |
D979516 | Al-Ali et al. | Feb 2023 | S |
D980091 | Forrest et al. | Mar 2023 | S |
11596363 | Lamego | Mar 2023 | B2 |
11627919 | Kiani et al. | Apr 2023 | B2 |
11637437 | Al-Ali et al. | Apr 2023 | B2 |
D985498 | Al-Ali et al. | May 2023 | S |
11653862 | Dalvi et al. | May 2023 | B2 |
D989112 | Muhsin et al. | Jun 2023 | S |
11673041 | Kiani | Jun 2023 | B2 |
11678829 | Al-Ali et al. | Jun 2023 | B2 |
11692934 | Normand et al. | Jul 2023 | B2 |
20010034477 | Mansfield et al. | Oct 2001 | A1 |
20010039483 | Brand et al. | Nov 2001 | A1 |
20020010401 | Bushmakin et al. | Jan 2002 | A1 |
20020058864 | Mansfield et al. | May 2002 | A1 |
20020133080 | Apruzzese et al. | Sep 2002 | A1 |
20030013975 | Kiani | Jan 2003 | A1 |
20030018243 | Gerhardt et al. | Jan 2003 | A1 |
20030144582 | Cohen et al. | Jul 2003 | A1 |
20030156288 | Barnum et al. | Aug 2003 | A1 |
20030212312 | Coffin, IV et al. | Nov 2003 | A1 |
20040002634 | Nihtila | Jan 2004 | A1 |
20040106163 | Workman, Jr. et al. | Jun 2004 | A1 |
20050055276 | Kiani et al. | Mar 2005 | A1 |
20050234317 | Kiani | Oct 2005 | A1 |
20060073719 | Kiani | Apr 2006 | A1 |
20060189871 | Al-Ali et al. | Aug 2006 | A1 |
20070073116 | Kiani et al. | Mar 2007 | A1 |
20070180140 | Welch et al. | Aug 2007 | A1 |
20070244377 | Cozad et al. | Oct 2007 | A1 |
20080064965 | Jay et al. | Mar 2008 | A1 |
20080094228 | Welch et al. | Apr 2008 | A1 |
20080221418 | Al-Ali et al. | Sep 2008 | A1 |
20090036759 | Ault et al. | Feb 2009 | A1 |
20090093687 | Telfort et al. | Apr 2009 | A1 |
20090095926 | MacNeish, III | Apr 2009 | A1 |
20090247984 | Lamego et al. | Oct 2009 | A1 |
20090275844 | Al-Ali | Nov 2009 | A1 |
20090309891 | Karkanias et al. | Dec 2009 | A1 |
20100004518 | Vo et al. | Jan 2010 | A1 |
20100030040 | Poeze et al. | Feb 2010 | A1 |
20100099964 | O'Reilly et al. | Apr 2010 | A1 |
20100234718 | Sampath et al. | Sep 2010 | A1 |
20100270257 | Wachman et al. | Oct 2010 | A1 |
20110028806 | Merritt et al. | Feb 2011 | A1 |
20110028809 | Goodman | Feb 2011 | A1 |
20110040197 | Welch et al. | Feb 2011 | A1 |
20110082711 | Poeze et al. | Apr 2011 | A1 |
20110086712 | Cargill | Apr 2011 | A1 |
20110087081 | Kiani et al. | Apr 2011 | A1 |
20110118561 | Tari et al. | May 2011 | A1 |
20110137297 | Kiani et al. | Jun 2011 | A1 |
20110172498 | Olsen et al. | Jul 2011 | A1 |
20110230733 | Al-Ali | Sep 2011 | A1 |
20120123231 | O'Reilly | May 2012 | A1 |
20120165629 | Merritt et al. | Jun 2012 | A1 |
20120189990 | Bavelier et al. | Jul 2012 | A1 |
20120209084 | Olsen et al. | Aug 2012 | A1 |
20120226117 | Lamego et al. | Sep 2012 | A1 |
20120283524 | Kiani et al. | Nov 2012 | A1 |
20130023775 | Lamego et al. | Jan 2013 | A1 |
20130041591 | Lamego | Feb 2013 | A1 |
20130046206 | Preminger | Feb 2013 | A1 |
20130060147 | Welch et al. | Mar 2013 | A1 |
20130096405 | Garfio | Apr 2013 | A1 |
20130196297 | Anwar | Aug 2013 | A1 |
20130296672 | O'Neil et al. | Nov 2013 | A1 |
20130345921 | Al-Ali et al. | Dec 2013 | A1 |
20140004492 | O'Reilly et al. | Jan 2014 | A1 |
20140166076 | Kiani et al. | Jun 2014 | A1 |
20140180160 | Brown et al. | Jun 2014 | A1 |
20140187973 | Brown et al. | Jul 2014 | A1 |
20140275835 | Lamego et al. | Sep 2014 | A1 |
20140275871 | Lamego et al. | Sep 2014 | A1 |
20140275872 | Merritt et al. | Sep 2014 | A1 |
20140316217 | Purdon et al. | Oct 2014 | A1 |
20140316218 | Purdon et al. | Oct 2014 | A1 |
20140323897 | Brown et al. | Oct 2014 | A1 |
20140323898 | Purdon et al. | Oct 2014 | A1 |
20140323899 | Silberstein et al. | Oct 2014 | A1 |
20150005600 | Blank et al. | Jan 2015 | A1 |
20150011907 | Purdon et al. | Jan 2015 | A1 |
20150073241 | Lamego | Mar 2015 | A1 |
20150080754 | Purdon et al. | Mar 2015 | A1 |
20150099950 | Al-Ali et al. | Apr 2015 | A1 |
20160196388 | Lamego | Jul 2016 | A1 |
20160283665 | Sampath et al. | Sep 2016 | A1 |
20160367173 | Dalvi et al. | Dec 2016 | A1 |
20170024748 | Haider | Jan 2017 | A1 |
20170173632 | Al-Ali | Jun 2017 | A1 |
20170251974 | Shreim et al. | Sep 2017 | A1 |
20170311891 | Kiani et al. | Nov 2017 | A1 |
20180242926 | Muhsin et al. | Aug 2018 | A1 |
20180247353 | Al-Ali et al. | Aug 2018 | A1 |
20180247712 | Muhsin et al. | Aug 2018 | A1 |
20180256087 | Al-Ali et al. | Sep 2018 | A1 |
20180310823 | Al-Ali et al. | Nov 2018 | A1 |
20190117070 | Muhsin et al. | Apr 2019 | A1 |
20190239787 | Pauley et al. | Aug 2019 | A1 |
20190320906 | Olsen | Oct 2019 | A1 |
20190374713 | Kiani et al. | Dec 2019 | A1 |
20200060869 | Telfort et al. | Feb 2020 | A1 |
20200111552 | Ahmed | Apr 2020 | A1 |
20200113435 | Muhsin | Apr 2020 | A1 |
20200113488 | Al-Ali et al. | Apr 2020 | A1 |
20200113496 | Scruggs et al. | Apr 2020 | A1 |
20200113497 | Triman et al. | Apr 2020 | A1 |
20200113520 | Abdul-Hafiz et al. | Apr 2020 | A1 |
20200138288 | Al-Ali et al. | May 2020 | A1 |
20200138368 | Kiani et al. | May 2020 | A1 |
20200163597 | Dalvi et al. | May 2020 | A1 |
20200196877 | Vo et al. | Jun 2020 | A1 |
20200253474 | Muhsin et al. | Aug 2020 | A1 |
20200253544 | Belur Nagaraj et al. | Aug 2020 | A1 |
20200275841 | Telfort et al. | Sep 2020 | A1 |
20200288983 | Telfort et al. | Sep 2020 | A1 |
20200321793 | Al-Ali et al. | Oct 2020 | A1 |
20200329983 | Al-Ali et al. | Oct 2020 | A1 |
20200329984 | Al-Ali et al. | Oct 2020 | A1 |
20200329993 | Al-Ali et al. | Oct 2020 | A1 |
20200330037 | Al-Ali et al. | Oct 2020 | A1 |
20210022628 | Telfort et al. | Jan 2021 | A1 |
20210104173 | Pauley et al. | Apr 2021 | A1 |
20210113121 | Diab et al. | Apr 2021 | A1 |
20210117525 | Kiani et al. | Apr 2021 | A1 |
20210118581 | Kiani et al. | Apr 2021 | A1 |
20210121582 | Krishnamani et al. | Apr 2021 | A1 |
20210161465 | Barker et al. | Jun 2021 | A1 |
20210236729 | Kiani et al. | Aug 2021 | A1 |
20210256267 | Ranasinghe et al. | Aug 2021 | A1 |
20210256835 | Ranasinghe et al. | Aug 2021 | A1 |
20210275101 | Vo et al. | Sep 2021 | A1 |
20210290060 | Ahmed | Sep 2021 | A1 |
20210290072 | Forrest | Sep 2021 | A1 |
20210290080 | Ahmed | Sep 2021 | A1 |
20210290120 | Al-Ali | Sep 2021 | A1 |
20210290177 | Novak, Jr. | Sep 2021 | A1 |
20210290184 | Ahmed | Sep 2021 | A1 |
20210296008 | Novak, Jr. | Sep 2021 | A1 |
20210330228 | Olsen et al. | Oct 2021 | A1 |
20210386382 | Olsen et al. | Dec 2021 | A1 |
20210402110 | Pauley et al. | Dec 2021 | A1 |
20220039707 | Sharma et al. | Feb 2022 | A1 |
20220053892 | Al-Ali et al. | Feb 2022 | A1 |
20220071562 | Kiani | Mar 2022 | A1 |
20220096603 | Kiani et al. | Mar 2022 | A1 |
20220151521 | Krishnamani et al. | May 2022 | A1 |
20220218244 | Kiani et al. | Jul 2022 | A1 |
20220287574 | Telfort et al. | Sep 2022 | A1 |
20220296161 | Al-Ali et al. | Sep 2022 | A1 |
20220361819 | Al-Ali et al. | Nov 2022 | A1 |
20220379059 | Yu et al. | Dec 2022 | A1 |
20220392610 | Kiani et al. | Dec 2022 | A1 |
20230028745 | Al-Ali | Jan 2023 | A1 |
20230038389 | Vo | Feb 2023 | A1 |
20230045647 | Vo | Feb 2023 | A1 |
20230058052 | Al-Ali | Feb 2023 | A1 |
20230058342 | Kiani | Feb 2023 | A1 |
20230069789 | Koo et al. | Mar 2023 | A1 |
20230087671 | Telfort et al. | Mar 2023 | A1 |
20230110152 | Forrest et al. | Apr 2023 | A1 |
20230111198 | Yu et al. | Apr 2023 | A1 |
20230115397 | Vo et al. | Apr 2023 | A1 |
20230116371 | Mills et al. | Apr 2023 | A1 |
20230135297 | Kiani et al. | May 2023 | A1 |
20230138098 | Telfort et al. | May 2023 | A1 |
20230145155 | Krishnamani et al. | May 2023 | A1 |
20230147750 | Barker et al. | May 2023 | A1 |
20230210417 | Al-Ali et al. | Jul 2023 | A1 |
Number | Date | Country |
---|---|---|
10-0570826 | Apr 2006 | KR |
Number | Date | Country | |
---|---|---|---|
20230356071 A1 | Nov 2023 | US |
Number | Date | Country | |
---|---|---|---|
61916136 | Dec 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17372229 | Jul 2021 | US |
Child | 18312150 | US | |
Parent | 17118323 | Dec 2020 | US |
Child | 17372229 | US | |
Parent | 16402903 | May 2019 | US |
Child | 17118323 | US | |
Parent | 14571286 | Dec 2014 | US |
Child | 16402903 | US |